Background:13C-hiolein is a purified algal triglyceride which is synthesized with 98% of all carbon atoms of the molecule uniformly 13C-labeled. Orlistat is the new name for tetrahydrolipstatin (THL), which is a specific and potent inhibitor of gastrointestinal lipases which induces artificial fat malabsorption in humans. The aim of the present study was to use the 13C-hiolein breath test (HBT) to assess THL-induced fat malabsorption in healthy volunteers. Methods: Eight healthy volunteers of normal body weight underwent 2 study periods of 4 days of diet with or without THL 120 mg t.i.d. On day 5, a HBT was performed. 13CO2 recovery in breath samples was measured over 24 h by isotope ratio mass spectrometry. Results: The peak 13CO2 excretion occurred only after 5 h in both treatment groups with little difference during the first 4 h between the groups. THL potently reduced fat digestion and absorption with the most pronounced effect observed after 8 h: 1.1± 0.2 vs. 2.3 ± 0.3% dose in control experiments (p < 0.05). The 24-hour cumulative 13CO2 excretion was also significantly reduced by THL: 14.9 ± 2.2 vs. 28.4 ± 4.1% dose in control experiments (p < 0.05). In 6 of the 8 subjects, the cumulative 13CO2 excretion was lower with THL 120 mg t.i.d. than with placebo. Conclusion: The HBT well reflects THL-induced artificial fat maldigestion in healthy volunteers.

1.
Rosenberg IH, Sitrin MD: Screening for fat malabsorption. Ann Intern Med 1981;95:776&ndash;777.
[PubMed]
2.
West PS, Levin GE, Griffin GE, et al: Comparison of simple screening tests for fat malabsorption. Br Med J 1981;282:1501&ndash;1504.
3.
Van de Kamer JH, Huinink Ten BH, Weyers HA: Rapid method for determination of fat in faeces. J Biol Chem 1949;177:347&ndash;355.
4.
Stein J, Purschain B, Bieniek U, Caspary WF, Lembcke B: Near infrared reflectance analysis (NIRA): A new dimension in the investigation of malabsorption syndromes. Eur J Gastroenterol Hepatol 1994;6:889&ndash;894.
5.
Lembcke B, Braden B, Caspary WF: Exocrine pancreatic insufficiency: Accuracy and clinical value of the uniformly labelled 13C-hiolein breath test. Gut 1996;39:668&ndash;674.
[PubMed]
6.
Drummey GD, Benson JA Jr, Jones CM: Microscopical examination of the stool for steatorrhoea. N Engl J Med 1961;264:85&ndash;87.
7.
Khouri MR, Huang G, Shiau YF: Sudan stain of fecal fat: New insight into an old test. Gastroenterology 1989;96:421&ndash;427.
[PubMed]
8.
Simko V: Faecal fat microscopy: Acceptable predictive value in screening for steatorrhoea. Am J Gastroenterol 1981;75:204&ndash;208.
[PubMed]
9.
Ghosh SK, Littlewood JM, Goddard D, et al: Stool microscopy in screening for steatorrhoea. J Clin Pathol 1977;30:749&ndash;753.
[PubMed]
10.
Penfold WA, Keynes WM: Use of a standard fatty meal as a test for fat absorption. Ann Surg 1971;173:157&ndash;163.
[PubMed]
11.
King CE, Toskes PP: The use of breath tests in the study of malabsorption. Clin Gastroenterol 1983;12:591&ndash;610.
[PubMed]
12.
Watkins JB, Klein PD, Schoeller DA, et al: Diagnosis and differentiation of fat malabsorption in children using 13C-labeled lipids: Trioctanoin, triolein and palmitic acid breath tests. Gastroenterology 1982;82:911&ndash;917.
[PubMed]
13.
Klein PD, Hachey DL, Opekun AR, et al: Oxidation studies of a biosynthetic randomly 13C-labeled triglyceride. Gastroenterology 1991;100:A528.
14.
Braden B, Picard H, Posselt HG, et al: 13C-hiolein breath test indicates normalized fat digestion in children with cystic fibrosis under high dosage pancreatic enzyme replacement. Gastroenterology 1994;106:A599.
15.
Amann ST, Cintron M, Curington C, et al: 13C-hiolein/neolate breath test for fat maldigestion/malabsorption: Finally a fat breath test that works! Gastroenterology 1995;108:A270.
16.
Schoeller DA, Schneider JF, Solomons NW, et al: Clinical diagnosis with the stable isotope 13C in CO2 breath tests: Methodology and fundamental consideration. J Lab Clin Med 1977;90:412&ndash;421.
[PubMed]
17.
Turner JM, Lawrence S, Fellows IW, et al: 14C-triolein absorption: A useful test in the diagnosis of malabsorption. Gut 1987;28:694&ndash;700.
[PubMed]
18.
Newcomer AD, Hofmann AF, DiMagno EP, et al: Triolein breath test: A sensitive and specific test for fat malabsorption. Gastroenterology 1979;76:6&ndash;13.
[PubMed]
19.
Pedersen NT, Andersen BN, Marqversen J: Estimation of 14C-triolein assimilation as a test of lipid assimilation. Breath test or measurement of serum radioactivity? Scand J Gastroenterol 1982;17:309&ndash;316.
[PubMed]
20.
Einarsson K, Bjorkhem I, Eklof R, et al: 14C-triolein breath test as a rapid and convenient screening test for fat malabsorption. Scand J Gastroenterol 1983;18:9&ndash;12.
[PubMed]
21.
Benini L, Scuro LA, Menini E, et al: Is the 14C-triolein breath test useful in the assessment of malabsorption in clinical practice? Digestion 1984;29:91&ndash;97.
[PubMed]
22.
Borgstrom B: Mode of action of tetrahydrolipstatin: A derivative of the naturally occurring lipase inhibitor lipstatin. Biochim Biophys Acta 1988;962:308&ndash;316.
[PubMed]
23.
Hadvary P, Lengsfeld H, Wolfer H: Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin. Biochem J 1988;256:357&ndash;361.
[PubMed]
24.
Drent ML, Larsson I, William OT, et al: Orlistat, a lipase inhibitor, in the treatment of human obesity: A multiple dose study. Int J Obes Relat Metab Disord 1995;19:221&ndash;226.
[PubMed]
25.
Hussain Y, Guzelhan C, Odink J, et al: Comparison of the inhibition of dietary fat absorption by full versus divided doses of orlistat. J Clin Pharmacol 1994;34:1121&ndash;1125.
[PubMed]
26.
Drent ML, van der Veen EA: Lipase inhibition: A novel concept in the treatment of obesity. Int J Obes Relat Metab Disord 1993;17:241&ndash;244.
[PubMed]
27.
Hogan S, Fleury A, Hadvary P, et al: Studies on the antiobesity activity of tetrahydrolipstatin, a potent and selective inhibitor of pancreatic lipase. Int J Obes 1987;11(suppl 3):35&ndash;42.
You do not currently have access to this content.